Cabometyx (Cabozantinib) Price - Get 60% Off (Guide)

1. Is Cabometyx (Cabozantinib) covered by Medicare?

Yes. Most Medicare Part D plans include Cabometyx in their formularies. However, it is typically placed on a high-cost specialty tier (Tier 5) and may require prior authorization. Patients should contact their plan provider to confirm coverage, costs, and any documentation needed.

2. Are there savings programs for Cabometyx (Cabozantinib)?

Yes. The Exelixis Access Services (EASE) program offers:

• Co-pay support for eligible commercially insured patients

• A 30-day free trial program

• Assistance with insurance approvals, prior authorizations, and appeals

• Financial assistance referrals for uninsured or underinsured patients

3. How much will Cabometyx (Cabozantinib) cost per year?

Here’s how much Cabometyx (Cabozantinib) could cost per year for long-term treatment of advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and differentiated thyroid cancer:

4. Why is Cabometyx (Cabozantinib) so expensive?

Several factors contribute to the high cost of Cabometyx (Cabozantinib):

• Research and Development Costs: Developing oncology drugs like Cabometyx involves substantial investment in laboratory research, multiple phases of clinical trials, and FDA regulatory review. These costs—often in the hundreds of millions—are reflected in the drug’s price.

• Complex Manufacturing: Cabometyx is a complex small-molecule therapy that requires advanced manufacturing techniques and strict quality controls. These processes add to the cost of production and distribution.

• Limited Competition: Cabometyx is one of the few approved treatments for certain advanced cancers (e.g., RCC, HCC), giving the manufacturer pricing leverage in the absence of equally effective alternatives.

• Insurance Coverage Variability: Out-of-pocket costs for patients are heavily influenced by their insurance plan’s tier placement, coinsurance, and deductible. Specialty-tier placement in Medicare Part D can lead to higher copays unless offset by manufacturer assistance or the 2025 out-of-pocket cap.

• Dosage and Dispensing Pharmacy: The total cost of Cabometyx can also vary based on the prescribed dose (e.g., 20mg vs. 60mg) and which pharmacy fills the prescription. Some retail pharmacies charge significantly more than online or international options.

• Overall Cost of Cancer Treatment: As part of a broader oncology regimen, Cabometyx contributes to the already high cost of cancer care. In some clinical settings, studies have raised concerns about its cost-effectiveness relative to other therapies.

While the list price is high, access programs, insurance coverage, and international pharmacy options may substantially lower costs for eligible patients.